ETOPOSIDE, ATEZOLIZUMAB, PF-08634404, CARBOPLATIN clinical trials

C6461004 - A GLOBAL PHASE 2/3 INTERVENTIONAL STUDY OF PF-08634404 IN COMBINATION WITH CHEMOTHERAPY IN PARTICIPANTS WITH EXTENSIVE-STAGE SMALL CELL LUNG CANCER

This study is testing a new drug, PF-08634404, alongside standard chemotherapy, for people with a type of lung cancer called extensive-stage small cell lung cancer. Researchers want to see if this new combination can help people live longer and improve their health.